☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Approval
The US FDA Approves High Concentration of Boehringer Ingelheim's Cyltezo (Biosimilar, Humira)
May 2, 2024
X4 Pharmaceuticals’ Xolremdi Receives the US FDA’s Approval for the Treatment of WHIM Syndrome
April 30, 2024
Abbott's Esprit BTK System Gains the US FDA’s Approval for Chronic Limb-Threatening Ischemia (CLTI) Below-The-Knee (BTK)
April 30, 2024
The US FDA Approves the Label Update of Gilead’s Biktarvy for Pregnant Adults with HIV
April 29, 2024
MFDS Korea Approves Onconic Therapeutics’ JAQBO (Zastaprazan citrate) for Treatment of Gastroesophageal Reflux Disease (GERD) in A...
April 26, 2024
EMA Granted Extended Approval to Astellas’ XTANDI (Enzalutamide) for Recurrent Early Prostate Cancer Treatment
April 24, 2024
Load more...
Back to Home